We previously demonstrated that early control of invasive carcinoma treated with STING ligand was dependent on innate cytokines and was preserved in CD8-depleted mice as well as Rag-/- mice lacking T cells [6]. The gene discussed is CD8A; the disease is invasive carcinoma.